Bruker is the leader in MALDI based microbial identification. The MALDI Biotyper is the worldwide recognized solution for extensive and routine usage in the microbiology laboratory, and allows further complementary workflows, including MBT Sepsityper for direct identification from positive blood culture, subtyping applications and resistance testing. Additionally, Bruker offers molecular tests for Invasive Fungal Diseases and CPE, and the IR Biotyper, for strain typing targeting hospital hygiene management. In 2017 Bruker have expanded their offering with antimicrobial susceptibility testing (AST) of bacteria and yeasts, due to the acquisition of Merlin Diagnostika GmbH. Recently, Bruker completed the acquisition of a majority interest in Hain Lifescience GmbH, an infectious disease specialist with a broad range of molecular diagnostics solutions for the detection of microbial and viral pathogens, as well as for molecular antibiotic resistance testing.